• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Formulation, Development and Evaluation of delayed release
Formulation, Development and Evaluation of delayed release

... E.mail: Pallavi.yerramsetty@gmail.com Ph.No: 09491544390 ...
sued
sued

... (I) that patent information has not been filed with respect to the referenced NDA [a “Paragraph I certification”], (II) that the patent identified as claiming the referenced NDA has expired [a “Paragraph II certification”], (III) that the generic drug will not be marketed until the date on which the ...
The a7 Nicotinic Receptor Agonist ABT-107 Decreases L
The a7 Nicotinic Receptor Agonist ABT-107 Decreases L

... orally at 0.01 mg/kg, a dose that optimally reduced LIDs (Zhang et al., 2014). The decline in LIDs reached its plateau by 5 weeks of ABT-894 treatment. At week 6, the monkeys were also administered ABT-107 at 0.10 mg/kg (Fig. 4B). No further decline in LIDs was observed with ABT-894 and ABT-107 in c ...
Review Article TRANSDERMAL DRUG DELIVERY SYSTEM
Review Article TRANSDERMAL DRUG DELIVERY SYSTEM

... Delivery of drugs through the skin has been always a challenging area for research due to barrier properties exhibit by the outermost layer of skin stratum corneum. In the last two decades, the transdermal drug delivery system has become a proven technology that offers significant clinical benefits ...
DRUG ABSORPTION BY SUBLINGUAL AND RECTAL ROUTES
DRUG ABSORPTION BY SUBLINGUAL AND RECTAL ROUTES

... Relatively little is known regarding rectal drug administration for anaesthetic purposes. In principle, most drugs which are used for anaesthetic purposes can be used rectally in premedication. In this respect, attention should be directed to the elimination kinetics of the drug (short c. long elimi ...
Drug-Induced Hepatotoxicity: A Review
Drug-Induced Hepatotoxicity: A Review

... crucial factor for the overall health and well being (Subramaniam and Pushpangadan, 1999). Hepatotoxicity implies chemical-driven liver damage. Certain medicinal agents, when taken in overdoses and sometimes even when introduced within therapeutic ranges, may injure the organ. Other chemical agents, ...
Stability Indicating HPLC Method for Simultaneous Determination of
Stability Indicating HPLC Method for Simultaneous Determination of

... E-mail: kishor.s.jain@gmail.com January - February 2009 ...
Ophthalmic Preparations - triphasepharmasolutions.com
Ophthalmic Preparations - triphasepharmasolutions.com

... characteristics such as added substances, containers, metal particles and leakage for only ophthalmic ointments. In an effort to modernize this general chapter and align it to the other USP general chapters related to pharmaceutical dosage forms, the general chapter 771 is being revised to include t ...
Role of Pharmacokinetics and Metabolism in Drug Discovery and
Role of Pharmacokinetics and Metabolism in Drug Discovery and

... Drug research encompasses several diverse disciplines united by a common goal, namely the development of novel therapeutic agents. The search for new drugs can be divided functionally into two stages: discovery and development. The former consists of setting up a working hypothesis of the target enz ...
Full-Text PDF
Full-Text PDF

... The skin, being the largest organ in the human body, has various functions, including protecting the body from its external environment, from excessive water loss, friction and impact wounds, and from external stimuli that could potentially harm the body, whilst also providing sensory abilities [1]. ...
INTRAVENOUS INFUSION: INTRODUCTION ONE
INTRAVENOUS INFUSION: INTRODUCTION ONE

... As stated earlier, the rate of drug leaving the body is equal to the rate of drug entering the body (infusion rate) at steady state (). In other w ords, there is no net change in the amount of drug in the body, D B, as a function of time during steady state. Drug elimination occurs according to firs ...


... DNA probe in particular, can be useful in epidemiological studies in MDR-TB outbreaks [52]. These RFLP patterns derived from patients in an outbreak can allow drug resistance to be simultaneously identified, and, thus, the analysis would be potentially useful for guiding the correct choice of antitu ...
Module 1. Clinical pharmacology of drugs affecting the
Module 1. Clinical pharmacology of drugs affecting the

... A. 0.1 mg per hour B. * 0.5 mg per hour C. 1.0 mg per hour D. 1.5 mg per hour E. 2.5 mg per hour 81. A patient you follow in clinic has a well-known heroin abuse problem. Drugs which could potentially prevent an abstinence withdrawal syndrome during hospitalization include: methadone, nalbuphine, bu ...
Express Scripts 2015 Drug Trend Report Workers` Compensation
Express Scripts 2015 Drug Trend Report Workers` Compensation

... in chronic noncancer pain. Continued use beyond the acute phase involves both balancing analgesia with risks, and determining whether they are contributing to a clinically meaningful improvement in patient function. ...
Actonel 75mg and 150mg.pub
Actonel 75mg and 150mg.pub

... are taken once monthly. The manufacturer implies that this would improve patient compliance, but has not provided any published data to support this contention. The submitted evidence demonstrates similar efficacy and side-effect profile as risedronate sodium 5mg taken once daily. Improvements in ga ...
Ophthalmic adverse drug reactions to systemic drugs
Ophthalmic adverse drug reactions to systemic drugs

... Purpose To perform a comprehensive and systematic review regarding ophthalmic adverse drug reactions (ADRs) to systemic drugs to: (i) systematically summarize existing evidence, (ii) identify areas, ophthalmic ADRs or drugs that lacked systematization or assessment (namely drugs with original studie ...
Do physicians respond to the costs and cost
Do physicians respond to the costs and cost

... on the assumption that cost-sensitive patients can choose low-tier drugs, but prescription drugs cannot, by definition, be purchased at will. Instead, patients rely on physicians to write a prescription, wherein three interacting problems emerge: First, the physician may not know the price-sensitivi ...
多靶点药物作为神经保护剂用于治疗青光眼的合理性
多靶点药物作为神经保护剂用于治疗青光眼的合理性

... neuroprotective strategies alone are unlikely to succeed if the initial insult persists. It is therefore believed that treatment modalities that directly target both primary and secondary degeneration of the RGCs are required. Until now, there has been no neuroprotective agent indicated for the trea ...
Iboga - Scientific Information
Iboga - Scientific Information

... pharmaceuticals that can eliminate the opioid withdrawal syndrome and help opioid-dependent patients to give up the use of opiates such as morphine, heroin, methadone and oxycontin. Furthermore, standard pharmacological and psychological approaches used in the treatment of addiction have very limite ...
Author`s personal copy
Author`s personal copy

... in the case of an osmotic agent in a sealed container, a hydrostatic pressure equivalent to the osmotic pressure can build up over time. In applications for drug release, an open release port is necessary which limits the hydrostatic pressure due to the continuous drug flow through the release port. ...
Molecules that changed our Lives Synthetic Organic
Molecules that changed our Lives Synthetic Organic

... organic molecules for livingbeings.Today we shall know about synthetic organic chemicals used in medicine. Till the year 1856 scientists believed in the Vital Force Theory Proposed by Berzelius. According to this theory, a vital force( life force) is necessary for the production of organic compounds ...
a review on technologies, recent trends and regulatory aspects
a review on technologies, recent trends and regulatory aspects

... (chemicals) can reach the olfactory epithelium via the nose (orthonasal route) or mouth (retronasal route) and information is then sent to glomeruli in the olfactory bulb to mitral cells traveling to higher centers in the brain. Person-to-person differences in the taste response to bitter chemicals ...
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS)
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS)

... Drugs increase the volume or decrease the viscosity of respiratory secretions, facilitate their removal by ciliary action and coughing. 1.1Mucolytic expectorants: Drugs alter chemical characteristics of sputum to decrease its viscosity and to facilitate its removal by ciliary action or coughing. eg. ...
taste masking methods and agents in pharmaceutical formulations
taste masking methods and agents in pharmaceutical formulations

... Taste is a critical factor during development of any dosage form and it is important parameter in administering drugs orally. Undesirable and particularly bitter taste is one of the important formulation problems that are encountered with many drugs. Proven methods for bitterness reduction and inhib ...
CONVENTIONAL AND NOVEL APPROACHES FOR COLON - e-JST
CONVENTIONAL AND NOVEL APPROACHES FOR COLON - e-JST

... formulation approach has also been found to be effective in minimizing unwanted side-effects13. Absorption of drugs via colonic delivery is desirable for chronotherapy as formulation present in the colon for longer time. Diseases such as asthma, hypertension, cardiac arrhythmias, arthritis or inflam ...
< 1 ... 5 6 7 8 9 10 11 12 13 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report